Global Pain Management Devices Market Size To Reach $5.76 Billion By 2028: Allied Market Research
26 juil. 2021 08h27 HE
|
Allied Market Research
Portland, OR, July 26, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Pain Management Devices Market garnered $3.68 billion in 2020, and is expected...
Global Oncology Partnering Report 2021: Deal Trends, Players and Financials for 4700 Deals
21 juil. 2021 04h48 HE
|
Research and Markets
Dublin, July 21, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2015-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Oncology Partnering Directory 2020 - Access to Over 4,000 Oncology Deal Records
05 févr. 2021 08h28 HE
|
Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2015-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Cancer Pain Pipeline Review, H2 2020 Report - Therapeutics Assessment of 36 Companies & Respective Drug Profiles
23 déc. 2020 08h43 HE
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Cancer Pain - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Cancer Pain - Pipeline Review, H2 2020,...
Sorrento Therapeutics Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) Epidural in Cancer Patients with Reported Intractable Pain
22 sept. 2020 14h30 HE
|
Sorrento Therapeutics, Inc.
Seventeen subjects with advanced cancer pain received epidural RTX (0.4 to 25 mcg).No dose limiting toxicities were reported.A majority of patients reported meaningful pain reduction of 30% or more...
Sorrento Therapeutics Presents Interim Positive Results of Phase 1b Resiniferatoxin (RTX) in Cancer Pain Trial
27 févr. 2020 15h30 HE
|
Sorrento Therapeutics, Inc.
Fourteen subjects with advanced cancer pain received epidural RTX (04 to 15 ug)Most common treatment-related adverse event was transient post-procedure related painThree subjects at the higher doses...
Pain Management Therapeutics Market to Reach US$83.0 Billion by 2024; Transparency Market Research
28 sept. 2016 09h08 HE
|
Transparency Market Research
Albany - New York, Sept. 28, 2016 (GLOBE NEWSWIRE) -- With generic medicines accounting for a more than two-thirds of the global pain management therapeutics market, several small- and...